-
1
-
-
0004270125
-
-
edn 5. Baltimore: Williams & Wilkins
-
Kaplan NM: Clinical Hypertension, edn 5. Baltimore: Williams & Wilkins; 1990: 163-267.
-
(1990)
Clinical Hypertension
, pp. 163-267
-
-
Kaplan, N.M.1
-
2
-
-
0025333289
-
Evolution of the P450 gene superfamily: Animal-plant 'warfare,' molecular drive and human genetic differences in drug oxidation
-
Gonzalez FJ, Nebert DW: Evolution of the P450 gene superfamily: animal-plant 'warfare,' molecular drive and human genetic differences in drug oxidation. Trends Genet 1990, 6: 182-186.
-
(1990)
Trends Genet
, vol.6
, pp. 182-186
-
-
Gonzalez, F.J.1
Nebert, D.W.2
-
3
-
-
0030935831
-
Genetic polymorphisms in the human drug-metabolizing enzymes: Potential uses of reverse genetics to identify genes of toxicological relevance
-
Puga A, Nebert DW, McKinnon RA, Menon AG: Genetic polymorphisms in the human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit Rev Toxicol 1997, 27: 199-222.
-
(1997)
Crit Rev Toxicol
, vol.27
, pp. 199-222
-
-
Puga, A.1
Nebert, D.W.2
McKinnon, R.A.3
Menon, A.G.4
-
4
-
-
0033005767
-
Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene
-
Hunt SC, Geleijnse JM, Wu LL, et al.: Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene Am J Hypertens 1999, 12: 460-466.
-
(1999)
Am J Hypertens
, vol.12
, pp. 460-466
-
-
Hunt, S.C.1
Geleijnse, J.M.2
Wu, L.L.3
-
5
-
-
0031656257
-
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: Trials of hypertension prevention, phase II
-
Hunt SC, Cook NR, Oberman A, et al.: Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension 1998, 32: 393-401.
-
(1998)
Hypertension
, vol.32
, pp. 393-401
-
-
Hunt, S.C.1
Cook, N.R.2
Oberman, A.3
-
6
-
-
0033068862
-
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: Trials of hypertension prevention, phase II [review]
-
Schork NJ: Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II [review]. Curr Hypertens Rep 1999, 1:11-12.
-
(1999)
Curr Hypertens Rep
, vol.1
, pp. 11-12
-
-
Schork, N.J.1
-
7
-
-
0030932384
-
Functional foods
-
Farr DR: Functional foods. Cancer Lett 1997, 114: 59-63.
-
(1997)
Cancer Lett
, vol.114
, pp. 59-63
-
-
Farr, D.R.1
-
8
-
-
0032548138
-
Nutriceuticals for cardiovascular health
-
Cooke JP: Nutriceuticals for cardiovascular health. Am J Cardiol 1998, 82(10A):42S-46S.
-
(1998)
Am J Cardiol
, vol.82
, Issue.10 A
-
-
Cooke, J.P.1
-
11
-
-
84882469134
-
-
Edited by Simopoulos AP, Nestel PJ. Karger: Basel
-
Genetic Variation and Dietary Response, vol 80. Edited by Simopoulos AP, Nestel PJ. Karger: Basel; 1997.
-
(1997)
Genetic Variation and Dietary Response
, vol.80
-
-
|